Ohio State University researchers have figured out a way to reanimate human hearts in order to gain a better understanding of irregular heartbeats. “It’s amazing. You can see the heart start beating again, which gives us an opportunity to study it with high-speed, high-tech equipment,” said Vadim Fedorov, an OSU biologist who developed the technique, […]
Ablation
BSD Medical rebrands as Perseon, wins expanded FDA nod for MicroThermX
Ablative Solutions tests infusion ablation catheter as hypertension treatment
Minerva Surgical’s just an inch away from closing a $25.5M round
California women’s health company Minerva Surgical is just a stone’s throw from wrapping up an equity funding round slated to bring in $25.6 million.
Funding: InSightec raises $12.5M from Chinese backers
Israeli device maker InSightec added $12.5 million to its coffers thanks to the support of Chinese backers, the firm’s parent company announced.
Diabetes: Fractyl raises $40M, touts positive early results for ablation-based diabetes therapy
Massachusetts medical device maker Fractyl announced this week that it raised $40 million in support of its ablation-based approach to type 2 diabetes, which looks promising in early studies.
Shareholders sue Edap following FDA slip
St. Jude closes $200M NeuroTherm buy
Medtech titan St. Jude Medical (NYSE:STJ) officially entered the spinal pain market this week, announcing the close of its $200 million cash acquisition of NeuroTherm.
SonaCare lands a date with the FDA for prostate cancer therapy
North Carolina-based SonaCare Medical is getting a day with the FDA, but the company’s prospects are murky given that it’s going before an advisory panel that just rejected a technology similar to SonaCare’s Sonablate 450 prostate cancer therapy.
FDA panel votes against EDAP’s ultrasound prostate cancer ablation
DOJ declares $520k victory as Vascular Solutions refutes allegations
Vascular Solutions (NSDQ:VASC) issued a special statement this week after the U.S. Justice announced that it had won a $520,000 settlement after accusing the company of selling a medical device without proper FDA approval.
